Peptides comprising an immunodominant sequence derived from...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 38/17 (2006.01) C07K 14/47 (2006.01) C07K 14/705 (2006.01) C12P 21/00 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2301684

There is provided according to the present invention, a peptide comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein (MOG), nucleic acid molecules capable of encoding the peptide and the use of such peptide or nucleic acid in medical therapy or screening.

L'invention porte sur un peptide comportant une séquence immunodominante dérivant de la glycoprotéine de l'oligodendrocyte myélinique humain (MOG), sur des molécules d'acide nucléique codant pour ledit peptide, et sur l'emploi dudit peptide ou dudit acide nucléique à des fins de thérapie médicale et de criblage.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptides comprising an immunodominant sequence derived from... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides comprising an immunodominant sequence derived from..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides comprising an immunodominant sequence derived from... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1660115

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.